Immunotherapy in locally advanced cervical cancer: Integrating KEYNOTE-A18 into management strategies

Jeffrey A. How & Amir A. Jazaeri

In locally advanced cervical cancer (LACC), the benefit of PD-1 blockade was unknown. In KEYNOTE-A18, Lorusso et al.
Journal
Med
Authors
Jeffrey A. How, Amir A. Jazaeri
Funding
Cancer Center Support Grant

NCI NIH HHS

P30 CA016672